What Is Tirzepatide? 1 Weekly Shot in Plain Words
Tirzepatide is a weekly shot that copies two hormones
The weekly shot is what you'll notice first. Tirzepatide copies both after-meal hormones released by your intestine.
One is called GLP-1, a bowel hormone involved in sugar control and appetite. GLP-1 isn't insulin or metformin; your body makes this message itself.
FDA approval came in 2022. A doctor may prescribe tirzepatide for diabetes, weight care, or some cases of sleep apnea.
You can't buy the shot over the counter. Your doctor must decide whether it fits your health.
“Peptide” means a short protein chain. Your stomach would break the chain apart if you swallowed it.
This page gives you the drug's main actions. Only a review of your health can show whether it fits.
What is tirzepatide? It copies GLP-1, a gut hormone
A peptide is a short row of protein parts, and tirzepatide is one. It copies two after-food signals from your bowel, including GLP-1.
A fat-like part fastens the drug to albumin, one protein found in your blood. That hold keeps one shot working through the week [1].
Researchers published the first paper in 2018. They tested cells in a dish; mice given tirzepatide ate less and weighed less [1].
That paper also covered Phase 1, an early safety test in people. Compared with a sugar pill, those people had lower fasting sugar and weight.
A 2020 cell study compared the two gut hormones, called GIP and GLP-1. The GLP-1 part made pancreas cells release insulin for longer [2].
A second test of GLP-1 found the same longer release. That GLP-1 work was done in a dish, so it can't forecast your response.
The FDA approved tirzepatide in May 2022 for type 2 diabetes [7]. The GLP-1 work doesn't prove your likely result with type 2 diabetes.
Tirzepatide peptide has four parts you need to know
A man-made peptide is a short row of protein building blocks. You can't take tirzepatide as a pill because your stomach would break it apart.
- What it copies: GIP and GLP-1, the paper names for two after-meal hormones made in your bowel.
- Time for half to leave: about 5 days.
- How it is given: a shot under your skin.
- What studies used: weekly shots that began at 2.5 mg and rose as high as 15 mg over about five months.
Your body makes GIP and GLP-1, but it doesn't make tirzepatide. The shot acts like both hormones [1].
The GLP-1 part helps slow digestion. You can't know which change you'll notice first.
Tirzepatide has three uses approved by the FDA
The FDA hasn't approved tirzepatide for every illness. Its three approved uses don't include children.
- Type 2 diabetes: approval came in May 2022, with diet and exercise used beside the drug.
- Long-term weight care: approval came in November 2023 for obesity, or excess weight with another health problem. A body-size score compares weight with height; 30 meant obesity, while 27 also required another health problem.
- Moderate-to-severe sleep apnea: this use covers adults with obesity.
Before November 2023, weight care without diabetes wasn't on the label. The drug still isn't approved for type 1 diabetes [7].
Studies also covered liver scarring, heart failure, and heart disease in type 2 diabetes [9][12][15]. A study doesn't turn those uses into approved care.
Tirzepatide can change sugar, digestion, hunger, and weight
Tirzepatide copies GIP and GLP-1, the paper names for two gut hormones. Those hormones can change four parts of your health.
- Insulin: your pancreas releases more when your blood sugar is high.
- The hormone that raises sugar: less enters your blood after meals.
- Digestion: your stomach empties more slowly, so fullness may last.
- Hunger: your brain gets a stronger message to stop eating.
Studies found better blood sugar, weight, blood pressure, and cholesterol readings [1][2]. The blood test shows your average sugar over about three months.
GLP-1 has more effect on hunger and digestion. GIP adds help after meals, but neither name will tell you what you'll feel.
The Tirzepatide research page separates findings in people, mice, and cells. The GLP-1 dish findings still can't predict your result.
Tirzepatide can remain in your body for weeks
One shot doesn't leave your body within a week. Five days pass before roughly half the medicine has left.
Most of one dose is gone after about 25-35 days. That's five to seven rounds of slow clearing.
A 2020 study measured this timing [1]. A fat-like part keeps tirzepatide joined to albumin in your blood.
That slow clearing makes weekly shots possible. There isn't one set day when every effect stops.